This indicates that 30–40% of patients have deafness due to recurrent mutations in particular genes, such as GJB2 or SLC26A4. In fact, 25% (53/216 overall), and 42% (50/120 for early-onset) of the patients were diagnosed by those recurrent mutations. This evidence concerns the gene SLC26A4 and deafness.